Gagnon Advisors, LLC Care Dx, Inc. Transaction History
Gagnon Advisors, LLC
- $138 Million
- Q4 2024
A detailed history of Gagnon Advisors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 412,875 shares of CDNA stock, worth $8.43 Million. This represents 6.39% of its overall portfolio holdings.
Number of Shares
412,875
Previous 412,875
-0.0%
Holding current value
$8.43 Million
Previous $12.9 Million
31.42%
% of portfolio
6.39%
Previous 9.19%
Shares
16 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$99.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$54.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$49.2 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$45.1 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.09B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...